Benitec Biopharma prices $100 million stock offering at $13.50 per share
PositiveFinancial Markets

Benitec Biopharma prices $100 million stock offering at $13.50 per share
Benitec Biopharma has successfully priced its $100 million stock offering at $13.50 per share, a move that reflects strong investor interest and confidence in the company's future. This funding will likely support their ongoing research and development efforts, potentially leading to significant advancements in gene therapy. Such capital raises are crucial for biotech firms as they navigate the complex landscape of drug development.
— via World Pulse Now AI Editorial System







